<PAGE>   1

                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549
                                   FORM 10-QSB

[X]    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934.

       For the Quarter ending JULY 31, 2001
                                 -------------

[ ]    TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1943.

       For the Transition period from _______________ to ___________________


Commission File Number    33-24566-A

BIO-LOK INTERNATIONAL INC.
(Name of registrant in its charter)


     DELAWARE                                                  65-0317138
-------------------                                         -------------------
(State or other jurisdiction of                             (IRS  Employer
incorporation or organization)                              Identification No.)

312 S. Military Trail, Deerfield Beach, Florida             33442
------------------------------------------------            -----
(Address of principal executive offices)                    (Zip Code)

Registrant's Telephone Number, Including Area Code:             (954) 698-9998

----------------------------

Securities registered pursuant to Section 12 (b) of the Exchange Act:

 Title of each class                Name of each exchange on which registered
 Common Stock, $.01 par value       NASD OTC Bulletin Board


Securities registered pursuant to Section 12(g) of the Act:       None

Check whether the issuer (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
YES [X]  NO [ ].

Check whether the issuer has filed all documents and reports required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the distribution of
securities under a plan confirmed by a court (1997). YES [X] NO [ ]

As of April 30, 2001, the Registrant had 6,085,348 Common Stock shares
outstanding, at a par value $.01 per share.


<PAGE>   2



                                TABLE OF CONTENT

                                     PART I

Item 1. Financial Statements                                                 2
        Condensed Consolidated Statement of Operations for the three
                 and nine months ended July 31, 2001 and 2000
        Condensed Consolidated Balance Sheets as of  July 31, 2001
                 and October 31, 2000
        Condensed Consolidated Statements of Cash Flows for nine
                 months ended July 31, 2001 and 2000
        Notes to Condensed Consolidated Financial Statements
Item 2. Management's Discussion and Analysis of Financial Results of
        Operations                                                           6
        Financial Condition                                                  7

                                     PART II

Item 6. Exhibits, List and Reports on Form 8-K                               8

                                  -------------




<PAGE>   3
PART I

ITEM 1. FINANCIAL STATEMENTS

                           BIO-LOK INTERNATIONAL INC.
                 Condensed Consolidated Statement of Operations
                                   (Unaudited)

<TABLE>
<CAPTION>

                                         Three Months Ended                 Nine Months Ended
                                               July 31,                          July 31,
                                    ----------------------------       ----------------------------
                                       2001              2000             2001             2000
                                    ----------        ----------       ----------        ----------
<S>                                 <C>               <C>              <C>               <C>
NET SALES                           $  491,634        $  724,927       $1,795,440        $1,842,232
Cost of Goods Sold                     136,762           192,355          461,475           543,355
                                    ----------        ----------       ----------        ----------
GROSS PROFIT                           354,872           532,572        1,333,965         1,298,877
                                    ----------        ----------       ----------        ----------
Selling                                133,255            72,211          350,054           207,898
Admin. & General Exp.                  281,815           273,783          840,445           641,031
                                    ----------        ----------       ----------        ----------
                                       415,070           345,994        1,190,499           848,929
                                    ----------        ----------       ----------        ----------
OPERATING INCOME                       (60,198)          186,578          143,466           449,948
                                    ----------        ----------       ----------        ----------
Interest Expense                        36,798            31,163           93,088            77,758
                                    ----------        ----------       ----------        ----------
NET INCOME                          $  (96,996)       $  155,415       $   50,378        $  372,190
                                    ==========        ==========       ==========        ==========
Net Income Available to

Common Share Owners                 $      n/a        $  155,415       $   50,378        $  372,190
                                    ==========        ==========       ==========        ==========
Net Income per Common Share         $      n/a        $      .02       $      .01        $      .06
                                    ==========        ==========       ==========        ==========
Dividends per Common Share          $      -0-        $      -0-       $      -0-        $      -0-
                                    ==========        ==========       ==========        ==========
Average Common Shares
         Outstanding                 6,085,348         6,055,358        6,085,348         5,846,127

</TABLE>



            See Notes to Condensed Consolidated Financial Statements.




                                       2
<PAGE>   4


                           BIO-LOK INTERNATIONAL INC.
                      Condensed Consolidated Balance Sheets
                                   (Unaudited)


                                            July 31,           October 31,
                                              2001                 2000
                                           -----------         -----------
ASSETS

Current Assets
   Cash                                    $    16,925         $    63,024
   Accounts Receivable (Net)                   678,111             649,740
   Inventory                                 1,077,576           1,082,062
   Other Current Assets                        227,555              42,645
                                           -----------         -----------
Total Current Assets                         2,000,167           1,837,471
                                           -----------         -----------

Net Machinery & Equipment                      525,754             403,814
                                           -----------         -----------

Other Assets -- Inventory                      189,066            195,066
             -- Other                           14,768             16,906
                                           -----------         -----------
                                               203,834            211,972
                                           -----------         -----------
TOTAL ASSETS                               $ 2,729,755         $ 2,453,257
                                           ===========         ===========

LIABILITIES & EQUITY

Current Liabilities

   Revolving Loan                          $   522,126         $   475,980
   Accts. Payable & Accr. Exp                  164,561              58,625
   Accounts Payable - Other                     28,129              11,339
   Notes & Loans payable - current             155,857             160,137
   Liabilities under capital leases             57,969              38,581
   Due to related parties                       36,375              11,375
                                           -----------         -----------
Total Current Liabilities                      965,017             756,037
                                           -----------         -----------

Long-Term Liabilities

   Notes & Loans payable-noncurrent            248,502             272,803
   Liabilities under capital leases            191,309             149,868
                                           -----------         -----------
Total Long=-Term Liabilities                   439,811             422,671
                                           -----------         -----------

Total Liabilities                            1,404,828           1,178,708
                                           -----------         -----------

STOCKHOLDERS' EQUITY

  Common Stock - authorized
     15,000,000, par value $.01;
     outstanding 6,085,348 and
     6,085,348 shares respectively;             60,854              60,854
  Preferred Stock - authorized
     500,000 par value $.75;
     outstanding 0 shares;                           0                 n/a
  Paid-in Capital                            2,221,586           2,221,586
  Retained Earnings                         (1,007,891)         (1,007,891)
  Retained Earnings-Current Year                50,378
                                           -----------         -----------
  Total Equity                               1,324,927           1,274,549
                                           -----------         -----------

TOTAL LIABILITIES & EQUITY                 $ 2,729,755         $ 2,453,257
                                           ===========         ===========



            See Notes to Condensed Consolidated Financial Statements.



                                       3
<PAGE>   5



                           BIO-LOK INTERNATIONAL INC.
                 Condensed Consolidated Statement of Cash Flows
                                   (Unaudited)

                                                       Nine Months Ended
                                                              July 31,
                                                    --------------------------
                                                       2001            2000
                                                    ---------        ---------
OPERATING ACTIVITIES:
  Net Income (Loss)                                 $  50,378        $ 372,190
     Adjustments to reconcile:
  Depreciation                                         72,406           54,038
  Valuation of shares
  Change in Current assets & liabilities:
     (Incr.) decr. in accts. rec                      (28,371)        (293,974)
     (Incr.) decr. in inventories                      10,486           53,679
     (Incr.) decr. in prepaid & other                (182,772)           3,466
     (Incr.) decr. in deposits                              0              500
     Incr. (decr.) in A/P & Accr. exp                 122,726           27,461
                                                    ---------        ---------
  Net Cash (used) by Operating                         44,853          217,360
                                                    ---------        ---------
FROM INVESTING ACTIVITIES:

  Property, Plant & Equipment                        (194,346)         (35,068)
  Cash received in Orthogen Corp. purchase                  0            1,214
                                                    ---------        ---------
  Net Cash (used) by Investing Activities            (194,346)         (33,854)
                                                    ---------        ---------

FROM FINANCING ACTIVITIES:

  Net proceeds - revolving loan                        46,146           36,179
  Net proceeds - short term loan                       25,000                0
  Increase in Long Term Debt                           32,248         (164,106)
                                                    ---------        ---------
  Net Cash Used for Financing Activities              103,394         (127,927)
                                                    ---------        ---------

NET INCREASE (DECREASE) IN CASH                     $ (46,099)       $  55,579
      Cash - Beginning of Period                       63,024           17,079
                                                    ---------        ---------
      Cash - End of Period                          $  16,925        $  72,658
                                                    =========        =========
      Interest Paid                                 $  93,088        $  77,758
      Income Taxes Paid                             $     -0-        $     -0-




            See Notes to Condensed Consolidated Financial Statements.





                                       4
<PAGE>   6


                           BIO-LOK INTERNATIONAL INC.
               Notes to Condensed Consolidated Financial Statement
                                   (Unaudited)


NOTE A - BASIS OF PRESENTATION

The financial statements represent the activities of all the accounts of a
consolidated Bio-Lok International Inc. ("Bio-Lok"). The consolidated results
include the activities of Micro-Lok Mexico, Orthogen Corporation and the
establishment of Bio-Lok Australia.

Revenues are recognized as product is shipped; inventory is stated at lower of
average cost or market; inventory which is not expected to be sold in one year
is classified as long-term; and, property and equipment are stated at cost, less
accumulated depreciation.

NOTE B - NATURE OF BUSINESS

Bio-Lok is a manufacturer and distributor, both domestically and
internationally, of the MICRO-LOK(TM) PRECISION DENTAL IMPLANT SYSTEM. Micro-Lok
consists of a number of select implants (both screw and cylinder), related
prosthetics parts, devices, associated tools, and irrigated drills and reamers.
The Company markets its product line direct to the end user, via distributors
and independent representatives.

Revenues are attributable to the distribution and sale of its manufactured or
purchased for resale products. Products are distributed directly to clinicians
domestically and to distributors or related companies internationally who in-
turn market and sell the products to clinicians.

Micro-Lok Mexico S.A.deC.Y. functions as a sales operation for Mexico. Product
is shipped to location and redistributed to customers when purchased.

Orthogen Corporation is an advanced biomaterials R&D corporation. Orthogen,
together with researchers at the UMD-New Jersey Dental School and New York's
Hospital for Joint Diseases, uncovered basic and wide-ranging
surface-modification and bone growth enhancement techniques for controlling
cellular interaction.

Bio-Lok International Pty. Inc. was established in Australia late July 2001. The
entity operates as a sales organization established to develop the Australian
and New Zealand dental implant market. Product is shipped to the location and
redistributed to customers when purchased.

NOTE C - INVENTORIES

Inventories at July 31, 2001, and October 31, 2000, consisted of the following:

                                    July 31, 2001       October 31, 2000
                                    -------------       ----------------
        Raw Materials & Supplies     $    24,604          $    31,122
        Work in Process                  276,177              498,373
        Finished Goods                   965,861              747,633
                                     -----------          -----------
                                     $ 1,266,642          $ 1,277,128
                                     -----------          -----------

The net decrease in inventory for the current quarter from the prior quarter was
$55,606 and year-to-date totals $10,486. The decrease is attributable to product
losses incurred from a machine fire. Inventory classified as non-current and
included in finished goods was $189,066.

NOTE D - FIXED ASSETS

During the current quarter the company acquired limited new assets, but
year-to-date machinery, new computer hardware and software acquired totaled
$194,346. The machinery acquired was to improve production capacity and quality,
and the new system hardware and software was acquired to improve and update the
system, and to meet company requirements.

NOTE E - SUMMARIZED INCOME STATEMENT DATA OF BIO-LOK INTERNATIONAL INC.

At July 31, 2001, the income statement represents consolidated Bio-Lok
International Inc. For the quarter income from operations totaled a loss of $60k
and $97k at net income. The reduced result was attributable to lower
international sales realized and the continued development of the domestic
market. July results were significantly effected by the machine fire in the
manufacturing area that caused operations to cease for 3 weeks.





                                       5
<PAGE>   7

NOTE F - CHANGE IN BUSINESS ACTIVITY

Effective with the next quarter the company has expanded its product line with
the addition of a membrane that will be marketed as a part of the Micro-Lok
Precision Dental Implant System.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS

Effective 2001 Management elected to develop its domestic market. In the past
the company maintained only 10% of gross revenue from the domestic market with
the remaining 90% coming from international marketing activity. To this extent,
the company intends to hire a domestic sales staff. To date a national sales
manager and three salesmen have been hired. Additional staff will be brought on
board over the ensuing months.

Management expects revenue increases to be realized by late summer. Eventually
it is anticipated that the domestic sales growth will exceed 100% annually for
the initial years of the market development.

International sales and marketing activity has resulted in the continued
development of new markets. In the current quarter the Brazil started up and
additional countries are being solicited for the remainder of this year.

The company is continually looking for product to add to its existing product
line sold under the Micro-Lok Precision Dental Implant System. A membrane has
been added as of the fourth quarter and it expects to add a bone augmentation
material by years-end.

Management reported via Form 8-K on August 16, 2001, that it had a machine fire
in its factory that occurred July 13, 2001. Said machine fire required 30 days
to fully evaluate the potential impact on the companies operation and continued
ability to meet sales activity. The company lost four weeks of production as a
consequences of the fire before resuming manufacturing. Due to the loss of
production capacity domestic marketing and sales growth activity was slowed and
hire of added sales staff was delayed until such a time that production capacity
was back on-line to insure product is available to ship. International sales
activity was slowed by not being able to bring new accounts on-line and the
inability to fill and ship all orders due to lack of product, creating back
orders. Company intends to be current and have all back orders shipped by
October this year. This is being accomplished with overtime, subcontracting and
purchasing of product required to fill orders.

                              RESULTS OF OPERATIONS

VOLUME

Net sales for the quarter continued to decrease. The decrease was only 8% over
the prior quarter and was only 3% below prior year year-to-date sales. Sales
declined as business activity has slowed considerably, particularly in the
international markets. Effective with the next quarter management expects the
international sales activity to return to prior period levels and bring new
distributor relationships on-line. Additionally, increased sales results are
anticipated to be realized as the domestic market is developed, market
penetration is achieved and the hire of a sales staff is completed.





                                       6
<PAGE>   8

COST OF GOODS SOLD

Cost of goods sold for the quarter reflected no material change. Overall costs
increased slightly due to the continued development and testing of new products
- particularly the "Laser-Lok" implants, which is anticipated to be introduced
to the market early next year.

GROSS PROFIT

Gross profit for the period decreased by 3% due to the continued drop in sales
activity and managements position to retain manufacturing staff for the
continued development of new products. Overall, production costs have remained
in-line.

SELLING EXPENSES

Selling expenses continue to increase as the domestic sales and marketing
activity is expanded. For the current quarter expenses increased 84% over the
comparable period prior year and was 68% higher year-to-date over the same
period prior year. The development of the domestic market was on track but has
been delayed for a time due to the impact of the machine fire, which occurred in
early July. To insure product availability hire of added staff had been delayed
to avail the company to fill the pipeline since the fire, which resulted in
multiple machine replacements. Selling expenses will continue to increase at
high percentages as the domestic market is developed and penetrated.

ADMINISTRATIVE & GENERAL EXPENSES

Administrative and general expenses for the quarter increased by 3% over the
comparable period prior year and 31% year-to-date over the comparable prior year
period. The increased costs are due to higher compensation and benefit incurred,
professional and financial service fee expenses and the costs due to the system
upgrade currently being implemented.

OPERATING INCOME

Results from operations for the quarter was a loss of $60k though year-to-date
resulted in a profit of $143k. The lower results and loss for the past quarter
are a direct result of the lower sales achieved, the resulting fire in July
which halted the hiring of the domestic sales staff until production of product
could be assured.

INTEREST EXPENSE

Interest expense for the quarter increased by $5.6k or 18% over the comparable
quarter prior year and year-to-date the increase totaled $15k. The increase in
interest expense is a direct result of added financed fixed assets and the
higher revolving loan outstanding.

NET INCOME

Net income for the quarter was a loss of $97k and year-to-date performance
resulted in a profit of $50k. The results are considerably below last years
result and reflect managements decision to develop and staff the entrance into
its domestic market.

                               FINANCIAL CONDITION

NET CASH FLOW PROVIDED BY OPERATIONS

Cash flow for the quarter increased by $3k. Year-to-date it still reflects a
reduction of $46k. The change in cash is a direct result of the domestic market
development being completed via internal activities.

FINANCING

For the quarter no new financing activities have occurred, but year-to-date new
financing activities have been entered for the purchase of added machinery and
the acquisition of new computer hardware and software.





                                       7
<PAGE>   9

The current revolving asset-based loan has been continued on a month-to-month
basis and management anticipates that lender will continue to finance company
going forward. The company is investigating and anticipates to enter into a
permanent line of credit with lenders in the near future.

Additionally, the company intents to continue to look for added equity
financing. The financing can be either via a private placement or a secondary
offering. Any funds raised are to be utilized for marketing activities and
related general working capital support, and the acquisition of related and
allied entities.

PART II.

ITEM 6. EXHIBITS, LIST AND REPORTS ON FORM 8-K

        (a) Reports on Form 8-K filed August 16, 2001, on the  machine fire.






                                       8
<PAGE>   10


                                   SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the Registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                       BIO-LOK INTERNATIONAL INC. (Registrant)




Date: September 12, 2001               By: /s/ Bruce L. Hollander
                                           -------------------------------------
                                           Bruce L. Hollander, President

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report
has been signed below by the following persons on behalf of the Registrant and
in the capacities and on the date indicated per the final audit report issued by
accountants.

<TABLE>
<CAPTION>

                Signature                            Title
                ---------                            -----



<S>                                     <C>                                    <C>
/s/ Bruce L. Hollander                  President, CEO and Director            Date: September 12, 2001
----------------------------------
    Bruce L Hollander




/s/ Ingo K. Kozak                       VP - Finance, CFO, Secretary           Date: September 12, 2001
-----------------------------------     and Director
    Ingo K. Kozak

</Table>






                                       9